KPMA calls for deferment of obligatory drug reporting

Published: 2007-11-23 07:00:00

Updated: 2007-11-23 07:00:00

The Korea Pharmaceutical Manufacturers Association said on November 19 that the government's plan to oblige drug makers to report their supply of non-reimbursed medicines as well as insurance-covered drugs, which will take effective from January 1, 2008, should be implemented at least one year l...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK